Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06FTM
|
|||
| Former ID |
DNCL003703
|
|||
| Drug Name |
RG7221
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 2 | [1] | |
| Metastatic colorectal cancer [ICD-11: 2B91; ICD-10: C19] | Phase 2 | [2] | ||
| Company |
Roche
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037469) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Company report (Roche pipeline: July 27, 2017) | |||
| REF 4 | Bispecific antibodies and their applications | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.